Tiziana Moscato

Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant-eligible newly diagnosed multiple myeloma: a multicenter real-world experience.

Impact of daratumumab/bortezomib/thalidomide and dexamethasone induction therapy on chemo-free stem cell mobilization in transplant-eligible newly diagnosed multiple myeloma: a multicenter real-world experience.

Journal: Haematologica
Published: July 24, 2024

Effectiveness of CAR-T treatment toward the potential risk of second malignancies.

Effectiveness of CAR-T treatment toward the potential risk of second malignancies.

Journal: Frontiers in immunology
Published: February 08, 2024

Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation.

Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation.

Journal: Annals of hematology
Published: June 22, 2023

The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.

The power of telemedicine to improve CAR-T cell therapy programs: lessons learned from COVID-19 pandemic.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: February 17, 2023

Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.

Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high-dose melphalan and autologous stem cell transplantation.

Journal: Annals of hematology
Published: December 21, 2022

Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel.

Managing leukapheresis in adult and pediatric patients eligible for chimeric antigen receptor T-cell therapy: suggestions from an Italian Expert Panel.

Journal: Blood transfusion = Trasfusione del sangue
Published: September 23, 2022

Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.

Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.

Journal: Expert opinion on biological therapy
Published: August 31, 2021

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.

CART-Cell Therapy: Recent Advances and New Evidence in Multiple Myeloma.

Journal: Cancers
Published: April 23, 2021

Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience.

Netupitant/palonosetron without dexamethasone for preventing nausea and vomiting in patients with multiple myeloma receiving high-dose melphalan for autologous stem cell transplantation: a single-center experience.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: April 22, 2021

Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.

Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
Published: May 24, 2020

A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.

A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant.

Journal: Annals of hematology
Published: September 23, 2019

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials.

Journal: Expert review of hematology
Published: June 29, 2019
Showing 1-12 of 33

Last Updated: 09/26/2026